Kos Pharmaceuticals, Inc. (Nasdaq: KOSP) submitted a supplemental New Drug Application for a complete dosage range of Niaspan Caplet Formulation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE